Dr Mohamed Bouattour
- Spécialité
- Onco-hépatologie (thématique, carninome hépatocellulaire, cholangiocarcinome, cancers hépatiques rare)
- Hôpital
- Hôpital Beaujon (Clichy)
- Derniers articles
-
- Neoadjuvant and adjuvant nivolumab associated with irreversible electroporation in patients with BCLC a hepatocellular carcinoma and high risk of recurrence (NIVOLEP trial). (8 avr. 2026)
- Clinical impact of extrahepatic metastatic patterns in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab. (30 mars 2026)
- Atezolizumab-Bevacizumab in Very Elderly With Hepatocellular Carcinoma: Age Alone Is Not a Limiting Factor Except in ALBI Grade 3. (17 mars 2026)
- Detection of esophageal varices and prediction of hepatic decompensation in unresectable hepatocellular carcinoma using AI. (10 févr. 2026)
- Serum procalcitonin: A novel tumor biomarker for diagnosis and disease monitoring in fibrolamellar hepatocellular carcinoma. (6 févr. 2026)